CHF Solutions, Inc. (CHFS) Q3 2020 Results Conference Call November 10, 2020 9:00 AM ET Company Participants Claudia Drayton - CFO John Erb - Chairman and CEO Nestor Jaramillo - President and COO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good morning, and welcome to the CHF Solutions Earnings Conference Call for the Third Quarter Ended September 30, 2020. All participants will be in a listen-only mode. [Operator Instructions] After today???s presentation, there will be an oppo ...

For the quarterly period ended June 30, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10‑Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in its Charter) Delaware No. 68-0533453 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 12988 Valley View Road, Eden Prairie, MN 55344 (Address of Principal Executive Offices) (Zip Code) (952) 345-4200 (R ...

CHF Solutions, Inc. (CHFS) Q2 2020 Earnings Conference Call August 4, 2020 9:00 AM ET Company Participants Claudia Drayton - Principal Financial Officer & Principal Accounting Officer John Erb - Chairman & CEO Nestor Jaramillo - President & COO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Anthony Vendetti - Maxim Group Operator Good morning, and welcome to the CHF Solutions Earnings Conference Call for the Second Quarter Ended June 30, 2020. [Operator Instructions]. Participants of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10‑Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 001-35312 CHF SOLUTIONS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware No. 68-0533453 (State or Other ...

CHF Solutions Inc. (CHFS) Q1 2020 Earnings Conference Call May 12, 2020 9:00 AM ET Company Participants John Erb - Chairman, Chief Executive Officer Claudia Drayton - Chief Financial Officer Nestor Jaramillo - Chief Commercial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good morning and welcome to the CHF Solutions earnings conference call for the first quarter ended March 31, 2020. All participants will be in listen-only mode. Should you need assistance, please signal a ...

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 001-35312 CHF SOLUTIONS, INC. Eden Prairie, Minnesota 55344 (Address of principal executive offices including zip code) (952) 345-42 ...

CHF Solutions, Inc. (CHFS) Q4 2019 Earnings Conference Call March 3, 2020 9:00 AM ET Company Participants Claudia Drayton ??? Chief Financial Officer John Erb ??? Chief Executive Officer and Chairman Nestor Jaramillo ??? Chief Commercial Officer Conference Call Participants Jeffrey Cohen ??? Ladenburg Thalmann Operator Good morning, and welcome to the CHF Solutions Earnings Conference Call for the Fourth Quarter ended December 31, 2019. [Operator Instructions] Participants of this call are advised that the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10‑Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 001-35312 CHF SOLUTIONS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware No. 68-0533453 (State o ...

CHF Solutions, Inc. (CHFS) Investor Update Conference Call September 25, 2019 1:00 PM ET Company Participants Stuart Goldstein - Cincinnati Children???s Hospital Medical Center David Askenazi - Children???s Hospital of Alabama Shina Menon - Seattle Children???s Hospital Conference Call Participants Jeff Cohen - Ladenburg Thalmann & Co. Operator Good afternoon, and welcome to the CHF Solutions Investor Call. All participants will be in listen-only mode. [Operator Instructions] After today???s presentation, t ...

Financial Highlights - CHF Solutions had approximately 27 million common shares outstanding with a market cap of approximately $6 million as of September 16, 2019 [6] - The company experienced 9 consecutive quarters of double-digit revenue growth [6] - Year 2018 revenue grew 41% compared to 2017 [6] - Q2 2019 revenue was up 53% from Q2 2018 and 38% from Q1 2019 [6] - As of June 30, 2019, CHF Solutions had $74 million in cash on hand and no debt [6] Aquadex FlexFlow System - Aquadex FlexFlow removes 40% more fluid than conventional diuretic drug therapy [24] - Aquadex FlexFlow is associated with a 53% reduction in the risk of heart failure rehospitalization at 90 days compared to diuretics [24] Market Opportunity - The addressable US market segments for Aquadex FlexFlow total over $2 billion annually [80] - The company estimates a $950 million market opportunity in critical care, $900 million in heart failure, and $115 million in pediatrics [32] - There are over 6 million people in the US suffering from heart failure [36]